- Home
- LCUT vs ATOS Comparison
LCUT vs ATOS Comparison
Compare LCUT & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCUT
- ATOS
- Stock Information
- Founded
- LCUT 1945
- ATOS 2009
- Country
- LCUT United States
- ATOS United States
- Employees
- LCUT N/A
- ATOS N/A
- Industry
- LCUT Industrial Machinery/Components
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- LCUT Consumer Discretionary
- ATOS Health Care
- Exchange
- LCUT Nasdaq
- ATOS Nasdaq
- Market Cap
- LCUT 111.4M
- ATOS 96.8M
- IPO Year
- LCUT 1991
- ATOS 2012
- Fundamental
- Price
- LCUT $3.81
- ATOS $0.62
- Analyst Decision
- LCUT Buy
- ATOS Strong Buy
- Analyst Count
- LCUT 2
- ATOS 3
- Target Price
- LCUT $7.50
- ATOS $7.00
- AVG Volume (30 Days)
- LCUT 56.1K
- ATOS 699.0K
- Earning Date
- LCUT 05-08-2025
- ATOS 05-12-2025
- Dividend Yield
- LCUT 4.42%
- ATOS N/A
- EPS Growth
- LCUT N/A
- ATOS N/A
- EPS
- LCUT N/A
- ATOS N/A
- Revenue
- LCUT $682,952,000.00
- ATOS N/A
- Revenue This Year
- LCUT $3.23
- ATOS N/A
- Revenue Next Year
- LCUT $2.45
- ATOS N/A
- P/E Ratio
- LCUT N/A
- ATOS N/A
- Revenue Growth
- LCUT N/A
- ATOS N/A
- 52 Week Low
- LCUT $3.85
- ATOS $0.55
- 52 Week High
- LCUT $11.68
- ATOS $1.81
- Technical
- Relative Strength Index (RSI)
- LCUT 27.27
- ATOS 42.51
- Support Level
- LCUT $3.85
- ATOS $0.56
- Resistance Level
- LCUT $4.13
- ATOS $0.67
- Average True Range (ATR)
- LCUT 0.30
- ATOS 0.06
- MACD
- LCUT -0.07
- ATOS 0.00
- Stochastic Oscillator
- LCUT 6.62
- ATOS 43.75
About LCUT Lifetime Brands Inc.
Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.